Molecular Design in Synthetically Accessible Chemical Space via Deep
  Reinforcement Learning
  The fundamental goal of generative drug design is to propose optimized
molecules that meet predefined activity, selectivity, and pharmacokinetic
criteria. Despite recent progress, we argue that existing generative methods
are limited in their ability to favourably shift the distributions of molecular
properties during optimization. We instead propose a novel Reinforcement
Learning framework for molecular design in which an agent learns to directly
optimize through a space of synthetically-accessible drug-like molecules. This
becomes possible by defining transitions in our Markov Decision Process as
chemical reactions, and allows us to leverage synthetic routes as an inductive
bias. We validate our method by demonstrating that it outperforms existing
state-of the art approaches in the optimization of pharmacologically-relevant
objectives, while results on multi-objective optimization tasks suggest
increased scalability to realistic pharmaceutical design problems.
